{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:41:52Z","timestamp":1792856512602,"version":"4.5.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.xphs.2025.103766","type":"journal-article","created":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T23:25:11Z","timestamp":1742599511000},"page":"103766","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["PLGA\/TPGS nanoparticles for docetaxel delivery: The pegylation effect on nanoparticle physicochemical properties and uptake and cytotoxicity in prostate cancer cells"],"prefix":"10.1016","volume":"114","author":[{"given":"L\u00edvia de Queir\u00f3z Carvalho","family":"Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni Loureiro","family":"Raspantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana Palma","family":"Abriata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela Tavares","family":"Luiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Carolina Cruz","family":"de Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thais da Silva","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuel Paula","family":"Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon R\u00f3seo Paula Pessoa Bezerra","family":"de Menezes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Petrilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana Maldonado","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josimar O.","family":"Eloy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2025.103766_bib0001","unstructured":"World Health Organization. Global cancer observatory. Accessed September 26, 2023. https:\/\/gco.iarc.fr\/"},{"issue":"10","key":"10.1016\/j.xphs.2025.103766_bib0002","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1007\/s12094-015-1480-y","article-title":"Role of taxanes in advanced prostate cancer","volume":"18","author":"Cassinello","year":"2016","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.xphs.2025.103766_bib0003","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2165\/00003088-199936020-00002","volume":"36","author":"Clarke","year":"1999","journal-title":"Clin Pharmacokinet"},{"issue":"1-2","key":"10.1016\/j.xphs.2025.103766_bib0004","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.drup.2014.04.001","article-title":"Nanoways to overcome docetaxel resistance in prostate cancer","volume":"17","author":"Ganju","year":"2014","journal-title":"Drug Resist Updates"},{"key":"10.1016\/j.xphs.2025.103766_bib0005","unstructured":"Glenmark Farmac\u00eautica Ltda. Docetaxel: bula do profissional de sa\u00fade. S\u00e3o Paulo: Glenmark Farmac\u00eautica Ltda.; n.d."},{"key":"10.1016\/j.xphs.2025.103766_bib0006","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.msec.2017.03.266","article-title":"Poly-epsilon-caprolactone nanoparticles enhance ursolic acid in vivo efficacy against Trypanosoma cruzi infection","volume":"77","author":"Abriata","year":"2017","journal-title":"Mater Sci Eng C"},{"key":"10.1016\/j.xphs.2025.103766_bib0007","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.msec.2017.12.036","article-title":"Recent advances of PLGA micro\/nanoparticles for the delivery of biomacromolecular therapeutics","volume":"92","author":"Ding","year":"2018","journal-title":"Mater Sci Eng C"},{"issue":"2","key":"10.1016\/j.xphs.2025.103766_bib0008","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.nano.2016.07.012","article-title":"Nanocarriers in cancer clinical practice: a pharmacokinetic issue","volume":"13","author":"Giodini","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.xphs.2025.103766_bib0009","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.msec.2015.01.033","article-title":"Co-delivery of docetaxel and Poloxamer 235 by PLGA-TPGS nanoparticles for breast cancer treatment","volume":"49","author":"Tang","year":"2015","journal-title":"Mater Sci Eng C"},{"key":"10.1016\/j.xphs.2025.103766_bib0010","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.addr.2016.08.012","article-title":"Building the design, translation and development principles of polymeric nanomedicines using the case of clinically advanced poly(lactide(glycolide))\u2013poly(ethylene glycol) nanotechnology as a model: an industrial viewpoint","volume":"107","author":"Lakkireddy","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"issue":"24","key":"10.1016\/j.xphs.2025.103766_bib0011","doi-asserted-by":"crossref","first-page":"10748","DOI":"10.1039\/D1NR02065J","article-title":"Effects of polyethylene glycol on the surface of nanoparticles for targeted drug delivery","volume":"13","author":"Shi","year":"2021","journal-title":"Nanoscale"},{"issue":"1-2","key":"10.1016\/j.xphs.2025.103766_bib0012","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ijpharm.2017.07.018","article-title":"Recent advances in TPGS-based nanoparticles of docetaxel for improved chemotherapy","volume":"529","author":"Choudhury","year":"2017","journal-title":"Int J Pharm"},{"issue":"11","key":"10.1016\/j.xphs.2025.103766_bib0013","doi-asserted-by":"crossref","first-page":"8910","DOI":"10.1016\/j.actbio.2013.06.034","article-title":"Docetaxel-loaded nanoparticles based on star-shaped mannitol-core PLGA-TPGS diblock copolymer for breast cancer therapy","volume":"9","author":"Tao","year":"2013","journal-title":"Acta Biomater"},{"key":"10.1016\/j.xphs.2025.103766_bib0014","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.msec.2017.06.004","article-title":"Polymeric nanoparticles: a study on the preparation variables and characterization methods","volume":"80","author":"Crucho","year":"2017","journal-title":"Mater Sci Eng C"},{"key":"10.1016\/j.xphs.2025.103766_bib0015","doi-asserted-by":"crossref","unstructured":"Fessi H, Puisieux F, Devissaguet JP, Ammoury N, Benita S. Rapid communication nanocapsule formation by interfacial polymer deposition following solvent displacement.; 1989.","DOI":"10.1016\/0378-5173(89)90281-0"},{"issue":"1","key":"10.1016\/j.xphs.2025.103766_bib0016","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ijpharm.2005.03.024","article-title":"Biodistribution properties of nanoparticles based on mixtures of PLGA with PLGA-PEG diblock copolymers","volume":"298","author":"Beletsi","year":"2005","journal-title":"Int J Pharm"},{"issue":"5","key":"10.1016\/j.xphs.2025.103766_bib0017","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.biomaterials.2006.09.047","article-title":"Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery","volume":"28","author":"Cheng","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.xphs.2025.103766_bib0018","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.colsurfb.2014.10.007","article-title":"Enhanced antitumor efficacy of vitamin E TPGS-emulsified PLGA nanoparticles for delivery of paclitaxel","volume":"123","author":"Sun","year":"2014","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"10","key":"10.1016\/j.xphs.2025.103766_bib0019","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1016\/j.biomaterials.2014.01.003","article-title":"Effects of PEG tethering chain length of vitamin E TPGS with a Herceptin-functionalized nanoparticle formulation for targeted delivery of anticancer drugs","volume":"35","author":"Zhao","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.xphs.2025.103766_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfa.2021.127144","article-title":"PCL-TPGS polymeric nanoparticles for docetaxel delivery to prostate cancer: Development, physicochemical and biological characterization","volume":"627","author":"Raspantini","year":"2021","journal-title":"Colloids Surf A Physicochem Eng Asp"},{"key":"10.1016\/j.xphs.2025.103766_bib0021","article-title":"Co-administration of tariquidar using functionalized nanostructured lipid carriers overcomes resistance to docetaxel in multidrug resistant MCF7\/ADR cells","volume":"71","author":"Kim","year":"2022","journal-title":"J Drug Deliv Sci Technol"},{"issue":"2","key":"10.1016\/j.xphs.2025.103766_bib0022","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ijpharm.2017.05.054","article-title":"Efficacy assessment of self-assembled PLGA-PEG-PLGA nanoparticles: correlation of nano-bio interface interactions, biodistribution, internalization and gene expression studies","volume":"533","author":"Dimchevska","year":"2017","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2025.103766_bib0023","doi-asserted-by":"crossref","unstructured":"Takeuchi H, Kojima H, Yamamoto H, Kawashima Y. Evaluation of circulation profiles of liposomes coated with hydrophilic polymers having different molecular weights in rats. Vol 75.; 2001. www.elsevier.com\/locate\/jconrel","DOI":"10.1016\/S0168-3659(01)00368-6"},{"key":"10.1016\/j.xphs.2025.103766_bib0024","first-page":"41","article-title":"The effect of topology of PEG chain on the stability of micelles in brine and serum","author":"Wu","year":"2021","journal-title":"Colloids Interface Sci Commun"},{"key":"10.1016\/j.xphs.2025.103766_bib0025","first-page":"230","article-title":"Variations in metabolite profiles of serum coronas produced around PEGylated liposomal drugs by surface property","author":"Jang","year":"2023","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"1","key":"10.1016\/j.xphs.2025.103766_bib0026","article-title":"Confocal microscopy: principles and modern practices","volume":"92","author":"Elliott","year":"2020","journal-title":"Curr Protoc Cytom"},{"key":"10.1016\/j.xphs.2025.103766_bib0027","first-page":"2017","article-title":"Basic multicolor flow cytometry","author":"Maciorowski","year":"2017","journal-title":"Curr Protoc Immunol"},{"issue":"1","key":"10.1016\/j.xphs.2025.103766_bib0028","doi-asserted-by":"crossref","first-page":"e55497","DOI":"10.1371\/journal.pone.0055497","article-title":"Trypanosoma cruzi response to sterol biosynthesis inhibitors: morphophysiological alterations leading to cell death","volume":"8","author":"Kessler","year":"2013","journal-title":"PLoS One"},{"issue":"5-6","key":"10.1016\/j.xphs.2025.103766_bib0029","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000487144","article-title":"Inhibitory effects of benzaldehyde, vanillin, muscone and borneol on p-glycoprotein in caco-2 cells and everted gut sac","volume":"101","author":"Wang","year":"2018","journal-title":"Pharmacology"},{"issue":"1","key":"10.1016\/j.xphs.2025.103766_bib0030","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-62848-5","article-title":"Optimization of cell viability assays to improve replicability and reproducibility of cancer drug sensitivity screens","volume":"10","author":"Larsson","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.xphs.2025.103766_bib0031","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ijpharm.2017.09.054","article-title":"Technical aspects of preparing PEG-PLGA nanoparticles as carrier for chemotherapeutic agents by nanoprecipitation method","volume":"533","author":"Almoustafa","year":"2017","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2025.103766_bib0032","doi-asserted-by":"crossref","first-page":"9199","DOI":"10.2147\/IJN.S230376","article-title":"Co-delivery of docetaxel and salinomycin to target both breast cancer cells and stem cells by plga\/tpgs nanoparticles","volume":"14","author":"Gao","year":"2019","journal-title":"Int J Nanomedicine"},{"issue":"1-2","key":"10.1016\/j.xphs.2025.103766_bib0033","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijpharm.2016.01.021","article-title":"Impact of PEG and PEG-b-PAGE modified PLGA on nanoparticle formation, protein loading and release","volume":"500","author":"Rietscher","year":"2016","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2025.103766_bib0034","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ijpharm.2005.03.024","article-title":"Biodistribution properties of nanoparticles based on mixtures of PLGA with PLGA-PEG diblock copolymers","volume":"298","author":"Beletsi","year":"2005","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2025.103766_bib0035","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1080\/21691401.2022.2118758","article-title":"Folate receptor-targeted PLGA-PEG nanoparticles for enhancing the activity of genistein in ovarian cancer","volume":"50","author":"Patra","year":"2022","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"10.1016\/j.xphs.2025.103766_bib0036","doi-asserted-by":"crossref","first-page":"935","DOI":"10.2147\/IJN.S121881","article-title":"Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile","volume":"12","author":"Rafiei","year":"2017","journal-title":"Int J Nanomedicine"},{"issue":"25","key":"10.1016\/j.xphs.2025.103766_bib0037","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1016\/j.biomaterials.2013.04.052","article-title":"Cholic acid-functionalized nanoparticles of star-shaped PLGA-vitamin E TPGS copolymer for docetaxel delivery to cervical cancer","volume":"34","author":"Zeng","year":"2013","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.xphs.2025.103766_bib0038","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jconrel.2011.11.020","article-title":"Bone metastasis targeting: a novel approach to reach bone using Zoledronate anchored PLGA nanoparticle as carrier system loaded with Docetaxel","volume":"158","author":"Ramanlal Chaudhari","year":"2012","journal-title":"J Control Release"},{"issue":"11","key":"10.1016\/j.xphs.2025.103766_bib0039","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.1016\/j.actbio.2014.07.015","article-title":"Aspartic acid-based modified PLGA-PEG nanoparticles for bone targeting: in vitro and in vivo evaluation","volume":"10","author":"Fu","year":"2014","journal-title":"Acta Biomater"},{"key":"10.1016\/j.xphs.2025.103766_bib0040","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.colsurfb.2016.01.032","article-title":"Co-loaded paclitaxel\/rapamycin liposomes: development, characterization and in vitro and in vivo evaluation for breast cancer therapy","volume":"141","author":"Eloy","year":"2016","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"25","key":"10.1016\/j.xphs.2025.103766_bib0041","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1016\/j.biomaterials.2013.04.052","article-title":"Cholic acid-functionalized nanoparticles of star-shaped PLGA-vitamin E TPGS copolymer for docetaxel delivery to cervical cancer","volume":"34","author":"Zeng","year":"2013","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.xphs.2025.103766_bib0042","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ijpharm.2013.10.036","article-title":"Docetaxel-nicotinamide complex-loaded nanostructured lipid carriers for transdermal delivery","volume":"458","author":"Fan","year":"2013","journal-title":"Int J Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2025.103766_bib0043","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3390\/pharmaceutics15030915","article-title":"DOPE\/CHEMS-based EGFR-targeted immunoliposomes for docetaxel delivery: formulation development, physicochemical characterization and biological evaluation on prostate cancer cells","volume":"15","author":"Moreira T da","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xphs.2025.103766_bib0044","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejps.2014.04.014","article-title":"Enhanced bioavailability and intestinal uptake of Gemcitabine HCl loaded PLGA nanoparticles after oral delivery","volume":"60","author":"Joshi","year":"2014","journal-title":"Eur J Pharmaceut Sci"},{"key":"10.1016\/j.xphs.2025.103766_bib0045","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ijbiomac.2014.05.067","article-title":"Development and evaluation of paclitaxel loaded PLGA: poloxamer blend nanoparticles for cancer chemotherapy","volume":"69","author":"Gupta","year":"2014","journal-title":"Int J Biol Macromol"},{"issue":"4","key":"10.1016\/j.xphs.2025.103766_bib0046","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.mycmed.2017.07.004","article-title":"Assessment of in vitro antifungal efficacy and in vivo toxicity of Amphotericin B-loaded PLGA and PLGA-PEG blend nanoparticles","volume":"27","author":"Moraes Moreira Carraro","year":"2017","journal-title":"J Mycol Med"},{"issue":"4","key":"10.1016\/j.xphs.2025.103766_bib0047","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/jbm.b.34208","article-title":"Development of novel PLGA nanoparticles with co-encapsulation of docetaxel and abiraterone acetate for a highly efficient delivery into tumor cells","volume":"107","author":"Sokol","year":"2019","journal-title":"J Biomed Mater Res B Appl Biomater"},{"issue":"10","key":"10.1016\/j.xphs.2025.103766_bib0048","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1111\/jphp.13147","article-title":"Influence of PEGylation on PLGA nanoparticle properties, hydrophobic drug release and interactions with human serum albumin","volume":"71","author":"Samkange","year":"2019","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.xphs.2025.103766_bib0049","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"10.1016\/j.xphs.2025.103766_bib0050","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","article-title":"Liposomal drug delivery systems: from concept to clinical applications","volume":"65","author":"Allen","year":"2013","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.xphs.2025.103766_bib0051","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejpb.2019.05.006","article-title":"Effect of nanoparticle size and PEGylation on the protein corona of PLGA nanoparticles","volume":"141","author":"Partikel","year":"2019","journal-title":"Eur J Pharmaceut Biopharmaceut"},{"issue":"28","key":"10.1016\/j.xphs.2025.103766_bib0052","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1016\/j.biomaterials.2007.05.025","article-title":"The in vitro kinetics of the interactions between PEG-ylated magnetic-fluid-loaded liposomes and macrophages","volume":"28","author":"Martina","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.xphs.2025.103766_bib0053","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.colsurfb.2015.10.029","article-title":"Imaging-based analysis of liposome internalization to macrophage cells: effects of liposome size and surface modification with PEG moiety","volume":"136","author":"Lee","year":"2015","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.xphs.2025.103766_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123263","article-title":"PLA-PEG forming worm-like nanoparticles despite unfavorable packing parameter: formation mechanism, thermal stability and potential for cell internalization","volume":"643","author":"Robin","year":"2023","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2025.103766_bib0055","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.2042-7158.2011.01376.x","article-title":"Cellular delivery of PEGylated PLGA nanoparticles","volume":"64","author":"Pamujula","year":"2012","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.xphs.2025.103766_bib0056","article-title":"Drug-loaded PEG-PLGA nanoparticles for cancer treatment","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Pharmacol"},{"issue":"10","key":"10.1016\/j.xphs.2025.103766_bib0057","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12102180","article-title":"The internalization pathways of liposomes, PLGA, and magnetic nanoparticles in neutrophils","volume":"12","author":"Garanina","year":"2024","journal-title":"Biomedicines"},{"issue":"19","key":"10.1016\/j.xphs.2025.103766_bib0058","doi-asserted-by":"crossref","first-page":"7350","DOI":"10.1039\/D1NR07279J","article-title":"Cell-surface glycosaminoglycans regulate the cellular uptake of charged polystyrene nanoparticles","volume":"14","author":"Olivieri","year":"2022","journal-title":"Nanoscale"},{"issue":"7","key":"10.1016\/j.xphs.2025.103766_bib0059","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14071447","article-title":"Fluorescent PLGA nanocarriers for pulmonary administration: influence of the surface charge","volume":"14","author":"Areny-Balaguer\u00f3","year":"2022","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.xphs.2025.103766_bib0060","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00418-023-02183-8","article-title":"Opposite changes in the expression of clathrin and caveolin-1 in normal and cancerous human prostate tissue: putative clathrin-mediated recycling of EGFR","volume":"159","author":"Xie","year":"2023","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.xphs.2025.103766_bib0061","article-title":"Data from caveolin-1 upregulation contributes to c-Myc\u2013induced high-grade prostatic intraepithelial neoplasia and prostate cancer","volume":"1","author":"Yang","year":"2023","journal-title":"Am Assoc Cancer Res"},{"issue":"1","key":"10.1016\/j.xphs.2025.103766_bib0062","doi-asserted-by":"crossref","DOI":"10.1186\/1556-276X-6-260","article-title":"Novel docetaxel-loaded nanoparticles based on poly(lactide-co-caprolactone) and poly(lactide-co-glycolide-co-caprolactone) for prostate cancer treatment: formulation, characterization, and cytotoxicity studies","volume":"6","author":"Sanna","year":"2011","journal-title":"Nanoscale Res Lett"},{"issue":"1","key":"10.1016\/j.xphs.2025.103766_bib0063","doi-asserted-by":"crossref","DOI":"10.1186\/s12645-019-0048-x","article-title":"In vitro anticancer activity of folate-modified docetaxel-loaded PLGA nanoparticles against drug-sensitive and multidrug-resistant cancer cells","volume":"10","author":"Poltavets","year":"2019","journal-title":"Cancer Nanotechnol"},{"issue":"1","key":"10.1016\/j.xphs.2025.103766_bib0064","article-title":"High-density lipoproteins: a promising tool against cancer","volume":"1867","author":"Ossoli","year":"2022","journal-title":"Biochimica et Biophysica Acta (BBA) - Mol Cell Biol Lipids"},{"issue":"11","key":"10.1016\/j.xphs.2025.103766_bib0065","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10111801","article-title":"The anti-tumor and immunomodulatory effects of PLGA-based docetaxel nanoparticles in lung cancer: the potential involvement of necroptotic cell death through reactive oxygen species and calcium build-up","volume":"10","author":"Gupta","year":"2022","journal-title":"Vaccines"},{"issue":"17","key":"10.1016\/j.xphs.2025.103766_bib0066","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e37341","article-title":"In vitro study of a new theranostic smart niosomal nanostructure for direct delivery of docetaxel via anti-PSMA aptamer","volume":"10","author":"Nasri","year":"2024","journal-title":"Heliyon"},{"issue":"4","key":"10.1016\/j.xphs.2025.103766_bib0067","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s40005-019-00439-x","article-title":"Biocompatibility, biodegradation and biomedical applications of poly(lactic acid)\/poly(lactic-co-glycolic acid) micro and nanoparticles","volume":"49","author":"Elmowafy","year":"2019","journal-title":"J Pharm Investig"},{"issue":"5153","key":"10.1016\/j.xphs.2025.103766_bib0068","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1126\/science.8128245","article-title":"Biodegradable long-circulating polymeric nanospheres","volume":"263","author":"Gref","year":"1994","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.xphs.2025.103766_bib0069","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1021\/acs.biomac.2c00730","article-title":"Impact of polyethylene glycol (PEG) conformations on the in vivo fate and drug release behavior of PEGylated core-cross-linked polymeric nanoparticles","volume":"23","author":"Kanamaru","year":"2022","journal-title":"Biomacromolecules"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925002242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925002242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T19:30:39Z","timestamp":1748633439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354925002242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":69,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0022354925002242"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2025.103766","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PLGA\/TPGS nanoparticles for docetaxel delivery: The pegylation effect on nanoparticle physicochemical properties and uptake and cytotoxicity in prostate cancer cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2025.103766","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Pharmacists Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103766"}}